Introduction
Loss of blood flow to the brain during stroke causes ischemia and subsequent neuronal death. Tissue in the penumbra, which surrounds the ischemic core, has a gradient of anoxia/ischemia and undergoes repetitive depolarizing events called peri-infarct depolarizations. These waves of depolarization are thought to be critical for tissue death and core expansion (Mies et al., 1993; Ohta et al., 2001) . Peri-infarct depolarizations, also called anoxic depolarizations (ADs), are proposed to overwhelm the neuron's ionic homeostatic mechanisms so that loss of oxidative phosphorylation and ATP production results in neuronal death and dysfunction (Phillis et al., 1996; Lipton, 1999) . The components of the AD have been investigated for decades, but little consensus has been reached on the sequelae that lead to loss of the neuronal membrane potential and cell death, likely because of the complex and multifaceted insults that result during ischemia.
In the hippocampus, enhanced glutamate release during anoxia/ ischemia is likely caused by the combination of increased presynaptic vesicle exocytosis (Fleidervish et al., 2001 ) and reversal of the astrocytic excitatory amino acid transporter, resulting in activation of AMPA receptors and NMDA receptors (NMDARs) and consequential neuronal depolarization (Rossi et al., 2000) . Our work recently identified pannexin-1 (Panx1) channels as potential contributors to ADs because Panx1 is activated directly by ischemia in an NMDAR-independent manner or by overstimulation of the NMDAR itself (Thompson et al., 2006 (but see Madry et al., 2010) . Other components of the ischemic insult, such as hypoglycemia and increased extracellular K ϩ , may also activate Panx1 channels (Kawamura et al., 2010; Santiago et al., 2011) . Thus, the mechanisms of activation of Panx1 channels during the AD are likely to be diverse and have not been well characterized.
Several potential mechanisms of activation for Panx1 during anoxia and NMDAR overstimulation exist. These include truncation of the C terminal of Panx1 by caspases, as reported for apoptotic cells releasing ATP (Chekeni et al., 2010) , or by posttranslational modifications such as phosphorylation or nitrosylation (Zhang et al., 2008) . Panx1 activation by P2X7 receptors may be mediated by Src family kinases (SFKs) because disruption of P2X7 binding to SFKs with an interfering peptide prevented Panx1 opening by BzATP in J774 macrophages (Iglesias et al., 2008) . The SFKs are also known to be physically linked to the GluN2A and GluN2B subunits of NMDARs (Yu et al., 1997) where they function to phosphorylate NMDARs and increase channel mean open time, which potentiates receptor responses during chronic pain (Salter and Pitcher, 2012) . Interestingly, SFK activity increases in hippocampal neurons during ischemia (Takagi et al., 1997 (Takagi et al., , 1999 , raising the possibility that SFKs activate Panx1 during anoxia. Here we tested this idea in acute hippocampal slices and found that interfering with Src activation or a putative SFK phosphorylation site on Panx1 prevents anoxia-induced Panx1 opening.
Materials and Methods
Animals. All animal care protocols were approved by the University of Calgary's Animal Care and Use Committee in accordance with the Canadian Council on Animal Care guidelines. Experiments were performed on Sprague Dawley rats (postnatal days 21-32), unless otherwise indicated, that were housed on a 12 h light/dark cycle with ad libitum access to Purina Laboratory Chow and water.
Chemicals and reagents. All salts for making artificial CSF (aCSF; see below) were from Sigma-Aldrich. The NMDAR antagonists, D-APV (final concentration, 50 M) and R-CPP (5 M), as well as the pancaspase inhibitor zVAD-FMK (100 M, applied intracellularly) were from Tocris Bioscience. The SFK inhibitor, PP2 (10 M); its inactive analog, PP3 (10 M); tamoxifen; and probenecid (500 M) were from Sigma-Aldrich. The specific mimetic peptide inhibitor of Panx1, 10 panx (100 M, sequence WRQAAFVDSY) (Pelegrin and Surprenant, 2006; ; a scrambled control peptide to 10 panx ( sc panx, 100 M; ; the TAT-conjugated Panx1 Y308 interfering peptide, TAT-Panx1 305-318 (10 M, sequence YGRKKRRQR-RRLKVYEILPTFDVLH); and a TAT control peptide (10 M, sequence YGRKKRRQRRR) were from AnaSpec or New England Peptide. The C-terminal Panx1 antibody (␣-panx1; 1:1000 final dilution, 0.25 ng/l) was purchased from Invitrogen (catalog #488100, rabbit polyclonal). Anti-connexin-43 (␣-Cx43; 1:2000 final dilution, 0.3 ng/l) was from Abcam (catalog #ab11370, rabbit polyclonal) and was a generous gift from Dr. K. Sharkey (University of Calgary, Alberta, Canada). All drugs were made into aliquots dissolved in water or DMSO and were diluted to the final concentration in aCSF (see below; the final concentration of DMSO never exceeded 0.1%, and appropriate controls were performed as indicated).
Generation of conditional Panx1 knock-out mice. Embryonic stem cells from agouti mice containing flox sequences flanking exon 2 of the Panx1 gene (Panx1 flx/flx ; accession number NM_019482.2) were purchased from the Knockout Mouse Project (KO1434, Panx1_B01) and microinjected into C57BL6/J female mice. The first generation was screened based on coat color (agouti), and expression of the Panx1 flx/flx gene was confirmed by PCR using a sense primer (5Ј-ACCTAAGAGACGGA CCTG-3Ј) and an antisense primer (5Ј-GAATCAATCCTCTGTGCC T-3Ј). Homozygote Panx1 flx/flx were bred with C57BL6/J mice expressing cre recombinase-ERT 2 under the wolfram syndrome 1 (wfs1) promoter (Jax mice; B6;C3-Tg(Wfs1-cre/ERT2)3Aibs/J; stock number 009103). Subsequent generations were screened by PCR, and homozygous Panx1 flx/flx /homozygous wfs1-cre-ERT 2 mice were bred and backcrossed for at least six generations to yield the conditional Panx1 knock-out mouse (FlxPanx1-Cre). The knock-out of Panx1 in weaned FlxPanx-Cre mice was initiated by two to five intraperitoneal injections of tamoxifen (300 or 100 mg/kg, respectively) at 24 h intervals. Control mice received vehicle alone (corn oil plus 5% ethanol) in parallel with male siblings that received tamoxifen. Hippocampal slices were prepared as described below from animals 48 -96 h after the last intraperitoneal injection.
Acute hippocampal slice preparation. Rats or mice were anesthetized by isoflurane inhalation in air and decapitated; the brain was extracted, blocked, and mounted on a vibrating slicer (VT1200S; Leica) while submerged in an ice-cold solution consisting of the following (in mM): 87 NaCl, 2.5 KCl, 25 NaHCO 3 , 0.5 CaCl 2 , 7 MgCl 2 , 1.25 NaH 2 PO 4 , 25 glucose, and 75 sucrose, saturated with 95% O 2 /5% CO 2 . Transverse hippocampal slices were cut (370 m) and transferred into a chamber containing aCSF at 33°C for at least 1 h before experimentation. aCSF consisted of 120 mM NaCl, 26 mM NaHCO 3 , 3 mM KCl, 1.25 mM NaH 2 PO 4 , 1.3 mM MgCl 2 , 2 mM CaCl 2 , and 10 mM glucose and was saturated with 95% O 2 /5% CO 2 .
Electrophysiology. Slices were transferred to a recording chamber and continually perfused with aCSF (33-35°C) at a rate of 1-2 ml per minute. Visualization of hippocampal pyramidal neurons from the CA1 region was achieved via differential interface contrast (differential interference contrast) imaging with a BX51WI microscope (Olympus). Whole-cell patch-clamp recordings were obtained using borosilicate glass microelectrodes (Sutter Instrument) with a tip resistance of 3-5 M⍀ pulled using a P-1000 Flaming/Brown Micropipette Puller (Sutter Instrument) and filled with an intracellular solution containing 108 mM potassium gluconate, 2 mM MgCl 2 , 8 mM sodium gluconate, 8 mM KCl, 2.5 mM K 2 -EGTA, 4 mM K 2 -ATP, and 0.3 mM Na 3 -GTP at pH 7.25 with 10 mM HEPES. Some experiments were performed with 100 M zVAD-FMK, with a Panx1 antibody (0.25 ng/l, ␣-panx1), with the SFK inhibitor PP2 (10 M), or with a TAT-conjugated Panx1 Y308 interfering peptide (TAT-Panx1 305-318 ; 10 and 1 M). For experiments where drugs were included in the pipette solution, a minimum of 10 min was allowed for intracellular equilibration. Control experiments in which the vehicle, 0.01 or 0.1% DMSO, was added to the intracellular solution were also performed when appropriate and reported as "vehicle" in the text and figures.
Anoxic conditions were achieved by switching the perfusate with aCSF equilibrated with 95% Ar/5% CO 2 to displace oxygen, while maintaining pH at 7.4. These conditions typically yielded a pO 2 of Ͻ5 mmHg (Thompson et al., 2006) . Anoxia was applied after at least 5 min of a stable "normoxic" baseline holding current or for 10 min when blockers were applied intracellularly. Access resistance was always Ͻ25 M⍀, but if it exceeded 25 M⍀ during the anoxic depolarization, the cells were discarded from further analysis.
Western blots and immunocytochemistry. All analyses were performed on acute hippocampal slices prepared as described above. Slices were maintained in either control or anoxic aCSF, and after a 1 h exposure to drugs/anoxia, slices were quickly lysed in RIPA lysis buffer (Invitrogen) using a mini-Dounce homogenizer. Western blot analysis of hippocampal-neocortical brain slice lysates for target proteins was performed according to standard protocols. Briefly, slices were harvested with lysis buffer containing protease and phosphatase inhibitors. Total protein (25-50 g) was loaded in each SDS-PAGE well and transferred onto PVDF membrane. Membranes were blocked using 5% skim milk powder or 1% BSA in TBS-T (10 mM Tris, 100 mM NaCl, 1% Tween 20) for 1 h at room temperature and incubated in a primary antibody for 1-2 h at room temperature (or 4°C overnight), with gentle shaking. Blots were washed three times in TBS-T and incubated in secondary antibodies for 1-2 h at room temperature, with gentle shaking. Blots were then washed two times with TBS-T, incubated in ECL-Plus (PI32132; Pierce Chemical) substrate/reagent according to the manufacturer's protocol, and imaged and quantified using a UVP Biospectrum Imaging system.
For immunocytochemical analysis of Panx1 expression in FlxPanx1-Cre mice, animals were anesthetized with an intraperitoneal injection of sodium pentobarbital (0.1 ml/100 mg body weight) and perfused by cardiac puncture with PBS, followed by 4% paraformaldehyde (PFA). The brains were harvested and postfixed in 4% PFA overnight, and antigen retrieval was performed by exposure of whole brains to 10 mM sodium citrate in 0.05% Tween, pH 6.0, at 85°C for 15-25 min. Brains were then cryoprotected with 30% sucrose for 24 -48 h, cryosectioned (30 M thickness), and floated in PBS. Slices were permeabilized with 0.5% Triton X-100 in PBS for 10 min and incubated in a blocking solution (5% donkey serum and 0.2% Triton X-100) for 1 h. Primary antibodies against Panx1 (see above) were diluted 1:40 in a blocking solution, and slices were incubated at room temperature for 24 h. After three 10 min washes in PBS, cryosections were incubated in a secondary antibody (diluted in a blocking solution), Alexa Fluor 488, for at least 4 h. Sections were washed, mounted onto chrom alum-coated slides, coverslipped with Vectashield (Vector Laboratories), and visualized with a confocal microscope (SP5; Leica).
Data analysis and statistics. Electrophysiological data were digitized at 10 kHz and low-pass filtered at 1 kHz with a MultiClamp 700B amplifier and Digidata 1440A analog to digital convertor (Molecular Devices). Data were recorded using pCLAMP 10, Clampex 10.3, and Axoscope 10.3 (Molecular Devices) software and stored for future analysis with Clampfit 10.3, Origin 8 (OriginLab), and Excel (Microsoft). Statistical significance was determined by one-way ANOVA with the post hoc Tukey's test, two-paired t test, or two-sample t test, and significance was set at p Ͻ 0.05. All results are presented as means Ϯ SEM.
Results
Anoxia and ischemia are potent inducers of glutamate release in the hippocampus, which consequently activates NMDARdependent secondary currents leading to ADs (Martin et al., 1994) and neuronal death and dysfunction (Pulsinelli et al., 1982; Hansen, 1985; Pulsinelli, 1985; Frandsen et al., 1989; Choi and Rothman, 1990; Lipton, 1999; Rossi et al., 2007) . Here we exposed hippocampal slices to anoxia while recording from CA1 pyramidal neurons in the whole-cell configuration to investigate the mechanism of activation of Panx1 during the AD. We used anoxia instead of oxygen/glucose deprivation (OGD) to mimic ischemia because of substantially less swelling of the slice, allowing for longer recordings and pharmacological manipulations. Furthermore, we included 4 mM ATP in the patch pipette (postsynaptic neuron) to reduce the likelihood of direct Panx1 activation by ischemia-induced ATP depletion, allowing us to isolate NMDAR effects.
Typical responses of CA1 neurons to anoxia are shown in Figure 1 A. CA1 pyramidal neurons underwent an AD 20.9 Ϯ 2.2 min (n ϭ 16) after removal of O 2 that was manifested as a substantial inward current (initial depolarization), with a mean Ϯ SEM peak value of Ϫ2.14 Ϯ 0.24 nA (n ϭ 16). The initial peak depolarization typically occurred within 10 min of onset ( Fig.  1 A) . The anoxia-induced current then relaxed toward the baseline, leaving a residual current (mean, Ϫ1.65 Ϯ 0.22 nA; n ϭ 16). AD inward currents were quantified as the peak amplitude (initial depolarization, within 10 min of onset) and the residual current amplitude (average current amplitude over 10 min calculated 10 min after the peak; Fig. 1 A) , which allowed us to determine the severity of the anoxic insult and the magnitude of the partial recovery, respectively. Furthermore, integration of the area under the current trace provided a reliable and reproducible measure of total charge transfer across the membrane (Fig. 1 D; 0.98 Ϯ 0.16 C at 10 min after the AD onset; n ϭ 16 for anoxia), which we used as an indicator of the degree of ionic dysregulation induced by anoxia. A drop in neuronal input resistance of Ͼ50% was associated with the AD peak current (Thompson et al., 2006) . This suggested opening of conductance pathways in the neurons that became unreliable to quantify, which is why we chose to examine charge transfer over long periods of time (i.e., 10 min).
Blockers of Panx1 channels attenuate the anoxic inward current
Panx1 channels are activated in acutely isolated hippocampal neurons by both overstimulation of NMDARs and directly by ischemia (Thompson et al., 2006 . To determine whether Panx1 contributes to the anoxia-induced inward current in CA1 pyramidal neurons in acute brain slices, we tested the effect of several Panx1 antagonists on the AD current. Bath application of the Panx1 inhibitor, 100 M 10 panx (Pelegrin and Surprenant, 2006; , significantly ( p Ͻ 0.05 vs no blockers) attenuated the initial depolarization by ϳ50% ( Fig. 1 ; control AD, Ϫ2.14 Ϯ 0.25 nA vs 10 panx, Ϫ1.05 Ϯ 0.29 nA; n ϭ 6). The residual current (Ϫ0.24 Ϯ 0.04 nA; n ϭ 6) also more closely approached the preanoxic baseline when Panx1 was blocked, so that 1.41 Ϯ 0.34 nA of inward current that normally persisted in unblocked neurons was absent. This "mean residual difference current" was calculated as the control residual current minus the 10 panx residual current. Additionally, the total charge transfer when Panx1 was blocked was 0.27 Ϯ 0.29 C (n ϭ 6) at 10 min after AD onset, leaving a mean difference charge transfer of 0.71 Ϯ 0.21 C. A scrambled version of the 10 panx peptide ( sc panx; n ϭ 8) did not significantly alter the AD current amplitude (initial depolarization, Ϫ2.21 Ϯ 0.26 nA; residual current, Ϫ1.78 Ϯ 0.28 nA; p Ͻ 0.05) or the net charge transfer (1.07 Ϯ 0.19 C at 10 min; p Ͻ 0.05) compared with anoxia alone (Fig. 1C) .
Other Panx1 blockers effectively attenuated the AD current, including 500 M probenecid (Silverman et al., 2008; Ransford et al., 2009 ) (residual current, Ϫ0.51 Ϯ 0.17 nA; n ϭ 5) and an antibody against the C terminal of Panx1, ␣-Panx1, when included in the patch pipette (residual current, Ϫ0.30 Ϯ 0.06 nA; n ϭ 6; Fig. 1 ). Inclusion of an antibody against ␣-Cx43, another member of the gap junction superfamily that is not expressed in neurons (Dermietzel et al., 1989; , failed to affect the AD (initial depolarization, Ϫ2.30 Ϯ 0.41 nA; residual current, Ϫ1.40 Ϯ 0.34 nA; n ϭ 9; p Ͼ 0.05 vs anoxia alone; Fig. 1C,D) . In all cases, block of Panx1 promoted recovery of the AD current to the preanoxic baseline (Fig.  1C) and dramatically reduced total charge transfer (i.e., ionic dysregulation) across the membrane (Fig. 1 D) , demonstrating that Panx1 is activated during exposure of hippocampal CA1 pyramidal neurons to anoxia.
Conditional knock-out of Panx1 attenuates AD currents
Pharmacological blockers of pannexins, connexins, and innexins (the gap junction superfamily) can lack specificity and inhibit several family members (Bruzzone et al., 2005) . In the case of the peptide inhib- itor of Panx1, 10 panx, it seems to also block connexin 46, although this protein has expression that is primarily restricted to the lens in rodents (Bruzzone et al., 2005) . Nevertheless, and despite the appropriate pharmacological controls (Fig. 1C) , we sought to confirm a role for Panx1 in the AD independently of pharmacological interventions. To this end, we generated conditional Panx1 knock-out mice by crossing mice with floxed exon 2 of the Panx1 gene with a tamoxifen-inducible cre-recombinase line driven by the wolfram syndrome 1 (wfs1) promoter (see Materials and Methods), which is highly expressed in the hippocampus (Luuk et al., 2008) . Intraperitoneal injections of tamoxifen to 21-to 35-d-old mice induced deletion of Panx1 as indicated by loss of immunoreactivity to ␣-Panx1 (Fig. 2A) .
The response of murine CA1 pyramidal neurons (from vehicleinjected FlxPanx1-Cre mice) to anoxia was similar to that measured in rat neurons (Fig. 2B-D) . However, knock-out of Panx1 attenuated ADs (Fig. 2B-D) ; the initial depolarization was significantly (p Ͻ 0.05) smaller in the tamoxifen-injected animals compared with that in vehicle controls (initial depolarization: vehicle, Ϫ1.87 Ϯ 0.41 nA, n ϭ 7; tamoxifen, Ϫ1.10 Ϯ 0.21 nA, n ϭ 9). Furthermore, recordings from the tamoxifen-treated FlxPanx1-Cre mice had significantly reduced ionic dysregulation (charge transfer, 0.38 Ϯ 0.08 C 10 min after onset; n ϭ 9) compared with vehicle-injected control animals (0.99 Ϯ 0.16 C; n ϭ 7; Fig.  2C ). Loss of Panx1 promoted recovery to the preanoxic baseline (i.e., residual current amplitude, Ϫ0.50 Ϯ 0.12 nA; p Ͻ 0.05 vs vehicle control; mean residual difference current, 1.00 Ϯ 0.31 nA; Fig. 2C ). Together with the data in Figure 1 , these results strongly support a role for Panx1 in inward currents and ionic dysregulation during anoxia.
Anoxia-induced opening of Panx1 is caspase cleavage independent
It was reported recently that Panx1 is activated during apoptosis by caspase cleavage of its C terminal (Chekeni et al., 2010; Sandilos et al., 2012) . Anoxia can be a potent inducer of both necrosis and apoptosis, suggesting that caspase modification of the Panx1 protein could be involved in channel opening during ADs. To test the possibility of caspase-dependent activation of Panx1 in our anoxia-induced AD model, we assessed changes in total Panx1 protein after anoxia, hypothesizing that immunoblotting of hippocampal lysates with the C-terminal-directed ␣-Panx1 should reveal a decrease in Panx1 band density and/or a mobility shift if the Panx1 C terminus is cleaved. As shown in Figure 3A , no detectable decrease in Panx1 immunoreactivity or mobility was detectable after a 1 h exposure to anoxia.
As an additional test for the potential role of caspases in Panx1 activation, we added the pan-caspase inhibitor zVAD-FMK (100 M) to the patch pipette and measured AD currents in CA1 hippocampal neurons. Neurons were dialyzed for at least 10 min before exposure to anoxic aCSF, with either vehicle (0.1% DMSO) or zVAD. Intracellular zVAD, at a concentration reported to prevent Panx1 C-terminal cleavage (100 M; Chekeni et al., 2010), did not alter the amplitude of the peak depolarization (Fig. 3 B, C ; initial depolarization, Ϫ1.59 Ϯ 0.27 nA; p ϭ 0.37; n ϭ 12) compared with vehicle alone (initial depolarization, Ϫ1.95 Ϯ 0.28 nA; n ϭ 8), nor did it improve the recovery toward baseline (Fig. 3 B, C; residual currents: vehicle, Ϫ1.28 Ϯ 0.19 nA; zVAD, Ϫ1.07 Ϯ 0.22 nA; p ϭ 0.5). Caspase inhibition by zVAD also failed to exhibit a significant reduction in ionic dysregulation compared with vehicle alone (Fig. 3D ; charge transfer, 0.75 Ϯ 0.18 C at 10 min from onset; p ϭ 0.55 vs vehicle).
Src family kinases are activated during anoxia, leading to Panx1 opening
Previous work has shown that inhibition of Panx1, activated by purinergic receptors, occurs in cell lines exposed to the SFK inhibitor PP2 (Iglesias et al., 2008) . This raises the possibility that SFKs regulate Panx1 opening in neurons in brain slices exposed to anoxia. We examined the Panx1 sequence and noted that the C terminus contains a putative phosphorylation site at tyrosine Y308 as part of a closely matched consensus sequence (YEEI) for SFKs (Bibbins et al., 1993; Songyang et al., 1993) . Incubation of hippocampal slices in anoxia increased SFK phosphorylation at Y416 by ϳ20%, and this increase was prevented by the SFK inhibitor PP2 (Fig. 4 A, B ) (Smart et al., 1981; Patschinsky et al., 1982) . PP3, the inactive analog of PP2, was ineffective at preventing SFK phosphorylation at Y416 (Fig. 4 A, B) . When PP2 was included in the patch pipette, the AD current was attenuated compared with PP3 ( Fig. 4C-E ; residual currents: PP3, Ϫ1.29 Ϯ 0.27 nA, n ϭ 7; PP2, Ϫ0.55 Ϯ 0.10 nA, n ϭ 6). Importantly, inclusion of PP3 in the patch pipette did not produce ADs that were significantly different ( p Ͼ 0.05) from the control response (i.e., compared with control samples from Fig. 1) .
We next sought to interfere with Panx1 at its SFK target sequence, Y308. This was achieved by inclusion of a small interfering peptide in the patch pipette or bath that comprised the amino acid sequence 305-318 of Panx1 conjugated to the TAT sequence for membrane permeability. The interfering peptide, TATPanx 305-318 (see Materials and Methods), in the bath dramatically attenuated anoxia-induced ADs in a manner similar to PP2 (Fig.  5) . Furthermore, to address the specificity of the Y308 site in single neurons, and to rule out possible effects of the peptide on the entire brain slice, TAT-Panx 305-318 was included in the patch pipette (TAT-Panx 305-318(i) ), where it potently blocked the AD (Fig. 5) . As an important negative control, the TAT peptide alone included in the patch pipette failed to alter the AD inward current ( Fig. 5 ; the mean difference charge transfer was not significant vs control without TAT peptide; p ϭ 0.86).
NMDARs are critical in the anoxia-induced inward current
NMDARs are important for generating ADs (Lee et al., 1999; Rossi et al., 2000) and can activate Panx1 , but the mechanisms linking the two remain unknown. Our recording conditions included 4 mM ATP in the patch pipette, suggesting that activation of Panx1 during anoxia is primarily attributable to enhanced glutamate release and is occurring independently of a fall in ATP in the postsynaptic neuron. To investigate a direct role for the NMDAR in the activation of Panx1, 50 M D-APV was included in the bath during anoxia. APV did not significantly delay the onset of the AD current (26.87 Ϯ 5.18 min) but significantly reduced the AD peak current ( Fig. 6A-C ; mean difference peak current, 1.08 Ϯ 0.29 nA; n ϭ 11; p Ͻ 0.05 compared with control from Fig. 1 ), promoted recovery toward the preanoxic baseline (Fig. 6 A, B ; mean residual difference current, 0.35 Ϯ 0.08 nA), and decreased charge transfer across the neuronal membrane ( Fig. 6C ; mean difference, 0.63 Ϯ 0.15 C from control). The NMDAR antagonist, 5 M R-CPP, was similarly effective as D-APV at inhibiting the AD currents (Fig. 6 B; n ϭ 5) . Coapplication of D-APV and 10 panx inhibited ADs by a similar magnitude to either drug alone (Fig.  6 B ; mean difference peak current, 0.95 Ϯ 0.32 nA; n ϭ 8; p Ͻ 0.05 vs 10 panx or D-APV alone), suggesting that NMDARs were required for Panx1 opening.
If the NMDAR is opening Panx1 and SFKs are involved as the data above suggest, it follows that NMDAR activation should lead to SFK phosphorylation at Y416. Incubation of acute hippocampal slices in 100 M NMDA and 10 M glycine to activate NMDARs leads to a marked increase in SFK phospho-Y416. PP2, but not PP3 or 1 M TAT-Panx 305-318 , blocked SFK activation (Fig. 6 D) , indicating that activation of NMDARs by exogenous NMDA (or endogenous glutamate release during anoxia; Fig. 4 ) leads to activation of SFKs.
Discussion
Here we have shown that anoxia, acting through NMDA receptors, activates Src kinases to open Panx1 channels and sustain the anoxic depolarization inward current. Antagonists of Panx1 channels reduced the peak amplitude of the anoxiainduced inward current and promoted recovery toward the preanoxic baseline, consequently decreasing charge transfer across the membrane. The role of Panx1 was further validated with a conditional knock-out mouse line that had confirmed lack of Panx1 expression in the hippocampus. The addition of the NMDAR antagonist D-APV together with the Panx1 blocker 10 panx did not result in further inhibition of AD currents above either blocker alone. Finally, we have demonstrated that anoxia and exogenous NMDA/glycine activated Src family kinases and that SFKs were responsible for opening Panx1, possibly via phosphorylation of Y308 on the Panx1 C terminal. Together, we have identified a signaling pathway that is important for the anoxic depolarization and involves NMDARs coupling to Panx1 via SFKs.
Contribution of Panx1 to anoxia-induced neuronal depolarization and death
It was recently suggested that Panx1 does not contribute to ADs in hippocampal neurons in brain slices because the nonselective gap junction superfamily blocker carbenoxolone failed to decrease OGD/ oxidative phosphorylation inhibitor-induced inward currents (Madry et al., 2010) . However, Madry and colleagues were able to block dye uptake by hippocampal neurons during ADs, which is suggestive of the opening of large-pore, pannexin-like channels (Bruzzone et al., 2005; Thompson et al., 2006) . Although we cannot explain why they failed to observe carbenoxolone-sensitive currents, our multipronged pharmacological and genetic approaches strongly support a role for Panx1 in the AD in hippocampal CA1 neurons in slices. One possibility is that the use of pharmacological blockers of the electron transport chain/glycolysis had direct effects on Panx1 or SFKs. Interestingly, glutamate receptor antagonists did not suppress ADs in rodent neocortex (Murphy et al., 2008) when measured directly with field electrodes or indirectly with intrinsic optical imaging, suggesting that the AD may have multiple origins that depend on brain region or developmental age.
The data presented here support our hypothesis that Panx1 functions to maintain ADs (MacVicar and Thompson, 2010) . The sequence of events during ADs and subsequent neuronal death appears to be that anoxia/ischemia promotes glutamate release from presynaptic terminals (Fleidervish et al., 2001 ) and reversal of the astrocytic excitatory amino acid transporter (Rossi et al., 2000) . Increased glutamate overstimulates NMDARs, which in turn activate SFKs and open Panx1. The depolarization of CA1 neurons during anoxia is likely initiated by ionotropic glutamate receptors, including AMPA and NMDARs (Yamamoto et al., 1997; Rossi et al., 2000) . Because we maintained 4 mM ATP in the postsynaptic neuron by inclusion in the pipette, this argues against Panx1 opening induced by a fall in ATP in the postsynaptic neuron . It is important to note that direct activation of Panx1 by ischemia (Thompson et al., 2006 ) is still possible during in vivo stroke (Zhang et al., 2008; Thompson and MacVicar, 2010) . Future studies will be aimed at blocking the NMDAR during ischemia and determining the intrinsic mechanism of Panx1 activation.
In our recordings, there is a portion of the AD inward current that remains even when NMDARs, Panx1, or both are blocked. This likely results from the activation of AMPA and NMDA receptors during increased glutamate release (Yamamoto et al., 1997) . Several other nonselective cation channels may govern the conductances responsible for AD currents. In addition to AMPA, NMDA receptors, and Panx1, the AD involves members of the transient receptor potential ( There are also numerous reports that Na ϩ influx (i.e., via Na ϩ / Ca 2ϩ , amiloride-sensitive Na ϩ exchanger) and voltage-dependent Na ϩ channels are (Chidekel et al., 1997; Yamamoto et al., 1997; White et al., 2012) or are not (Pisani et al., 1998; Banasiak et al., 2002) involved in depolarization and death of neocortical neurons. This emphasizes the variability and complexity of the response to ischemia that likely depends on both neuronal type (cortical vs hippocampal) and model system (culture vs acute slice). Indeed, it remains a challenge of the field to identify and characterize the mechanisms and temporal contributions of these nonselective cation channels to the AD in specific neuronal populations.
Sustained anoxic depolarizations are critical for dysregulation of intracellular Ca 2ϩ and neuronal death during excitotoxicity (Connor et al., 1988; Lee et al., 1999) . If Panx1 is important in sustaining the AD, as our data suggest, it would follow that knock-out of Panx1 would be neuroprotective during stroke. Indeed, recent work confirms the hypothesis that Panx1 is important in neuronal death during stroke because an independently generated mouse with constitutive genetic knockdown of Panx1 and Panx2 resulted in significantly reduced lesion volumes in mice after middle cerebral artery occlusion (Bargiotas et al., 2011) . Interestingly, death induced by Panx1 activation may be a common mechanism for many neurons, as emphasized by our recent report that Panx1 is involved in loss of enteric neurons during models of colitis and Crohn's disease (Gulbransen et al., 2012) .
Mechanisms of Panx1 opening during anoxia involve Src family kinases
Here we have explored two possible mechanisms of activation of Panx1 during anoxia. The first was the possibility that Panx1 was activated by cleavage of its C terminal by caspases, as has been reported for apoptotic cells releasing ATP (via Panx1) to call immune cells and initiate phagocytosis (Chekeni et al., 2010) . Whereas this interesting mechanism appears important in apoptosis, we were unable to detect either a decrease in Panx1 levels or a shift in Panx1 mobility on Western blots, suggesting that Panx1 is not being cleaved in our acute anoxic paradigm. As further support to this, no effect of the pan-caspase inhibitor zVAD-FMK, applied intracellularly at an effective concentration (Chekeni et al., 2010) , on anoxia-induced inward currents was observed. We cannot, however, rule out the possibility that Panx1 cleavage occurs later under chronic anoxic exposure and contributes to localized immune responses. Interestingly, Na ϩ influx during ischemia is reported to activate caspase-3 and subsequent neuronal apoptosis (Banasiak et al., 2004) , suggesting a link between delayed Na ϩ dysregulation and caspase-3-induced Panx1 opening to call phagocytotic cells (Chekeni et al., 2010) , as occurs hours to days after stroke (Dirnagl et al., 1999) . Figure 1 . C, Net cumulative charge transfer across the membrane with NMDAR block by D-APV or R-CPP. D, Top, Src family kinase activation in the presence of bathapplied NMDA/glycine (gly) assayed by Western blot analysis of phospho-Y416 levels. Bottom, Quantitative analysis of the relative (vs control) density of phospho-Src Y416. Band densities were normalized to GAPDH and expressed relative to control, which was set at zero for each gel. Application of NMDA/glycine was significantly different than control (one-way Student's t test vs a mean of 0). PP2 was significantly different ( p Ͻ 0.05) from NMDA/gly. All bands in the blot are from the same gel. Error bars are SEM.
The activation of Panx1 during exposure of CA1 neurons to anoxia seems to involve the Src family kinases. We demonstrate that SFKs have increased phosphorylation at Y416 during anoxia, which is a strong indicator of activation (Smart et al., 1981) . The SFK inhibitor PP2 prevented this activation and significantly attenuated Panx1 activity during the AD. Interestingly, an interfering peptide that mimicked the sequence of Panx1 between 305 and 318 (and contained the only known sequence similar to the SFK consensus site on Panx1) blocked channel activation during anoxia. Together, these data support a role for SFK-mediated activation of Panx1 during anoxia via phosphorylation of Y308 at the Panx1 C terminal. Unfortunately, commercially available Panx1 antibodies, in our hands, are not able to immunoprecipitate Panx1 so that direct analysis of the phosho-tyrosine state of the channel could not be investigated.
How are SFKs being activated during anoxia? It has been described that SFKs associate with NMDARs via postsynaptic density 95 (PSD95) through interaction of the PDZ3 domain of PSD95 and the SH2 domain of SFKs (Takagi et al., 1999) . This interaction seems important for augmentation of NMDAR currents in models of chronic pain (Salter and Pitcher, 2012) . However, a potential reciprocal relationship where NMDARs activate SFKs is also possible, and we demonstrate here that exogenous NMDA/glycine acted similarly to anoxia, inducing phosphorylation of SFKs at Y416.
In summary, we have identified a mechanism through which overstimulation of NMDARs by anoxia leads to opening of Panx1 channels by activation of SFKs. Given the important role of NMDARs and Panx1 in neuronal death during ischemia, our work has linked these two pathways via the Src family of tyrosine kinases. Thus, targeting SFKs, Y308 on Panx1, or the Panx1 channel pore itself represents novel strategies to treat pathological neuronal depolarizations similar to those that occur during stroke.
